Interestingly, these radiation-related stimulations of both tumour cell proliferation and tumour angiogenesis were markedly diminished by the presence of the drug combination, with the EGFR-targeting drug probably playing a role in the attenuation of radiation-induced tumour proliferation. Here, EGFR is linked to neoplasm.